If you are over 35 and struggling to conceive, you are not alone and you are not out of options. While fertility naturally declines with age, advances in reproductive medicine mean that women over 35 have more effective treatment options than ever before. The key is early evaluation and personalized care.
Why Fertility Changes After 35
Age is the single most significant factor affecting female fertility. A woman is born with all the eggs she will ever have. By age 35, both egg quantity and quality begin to decline more rapidly, a process driven by chromosomal changes within the eggs themselves.
According to the American Society for Reproductive Medicine (ASRM), fertility begins to decline gradually in the late 20s and more significantly after age 35, with a sharper drop after 40. A study published in Human Reproduction found that by age 35, approximately 94% of women can conceive within 3 years compared to 77% by age 38. Early evaluation and treatment make a measurable difference.
Step 1: Get a Complete Fertility Evaluation First
Before any treatment begins, your OB-GYN will conduct a thorough evaluation including:
- AMH (Anti-Müllerian Hormone) — measures ovarian reserve and egg supply
- Antral Follicle Count (AFC) via transvaginal ultrasound
- FSH, LH, and Estradiol — assess ovulatory function
- HSG (Hysterosalpingography) — checks for blocked fallopian tubes
- Thyroid and prolactin levels — hormonal causes that are highly treatable
This evaluation guides which treatment path is most appropriate for your specific situation.
Treatment Options for Women Over 35
Ovulation Induction
For women with irregular or absent ovulation, medications such as letrozole or clomiphene citrate stimulate the ovaries to produce and release eggs. Letrozole has become the preferred first-line treatment for women with PCOS-related infertility. A landmark study in the New England Journal of Medicine found letrozole significantly outperformed clomiphene in live birth rates in women with PCOS.
Intrauterine Insemination (IUI)
IUI involves placing prepared sperm directly into the uterus around the time of ovulation, increasing the chances of fertilization. It is often combined with ovulation induction. IUI is a less invasive and lower-cost first-line option for women over 35 with open fallopian tubes and adequate ovarian reserve.
In Vitro Fertilization (IVF)
IVF is the most effective fertility treatment available and is often recommended sooner for women over 35 due to the time-sensitive nature of ovarian reserve. The process involves stimulating the ovaries to produce multiple eggs, retrieving them, fertilizing them in a lab, and transferring a resulting embryo to the uterus.
According to the CDC’s 2021 Assisted Reproductive Technology (ART) Report, the live birth rate per IVF cycle using a patient’s own eggs is approximately 32% for women aged 35–37 and 21% for women aged 38–40. Success rates improve significantly when using preimplantation genetic testing (PGT) to screen embryos for chromosomal abnormalities, a key advantage for women over 35.
Preimplantation Genetic Testing (PGT)
PGT is performed on embryos before transfer during IVF. It identifies chromosomally normal embryos, reducing the risk of miscarriage and increasing the likelihood of a successful pregnancy. Research published in Fertility and Sterility found that PGT significantly improved live birth rates in women over 35 undergoing IVF.
Egg Freezing (Oocyte Cryopreservation)
For women over 35 who are not yet ready to conceive, egg freezing preserves eggs at their current quality. While success rates are higher when eggs are frozen before 35, egg freezing after 35 can still be a viable option depending on ovarian reserve. Your OB-GYN can help evaluate whether this is right for you.
Donor Eggs
When ovarian reserve is significantly diminished, using donor eggs from a younger woman can dramatically improve success rates. IVF with donor eggs has live birth rates of 40–50% per transfer, largely independent of the recipient’s age, according to SART (Society for Assisted Reproductive Technology) national data.
Treating Underlying Conditions
Many fertility challenges in women over 35 are caused or worsened by treatable conditions:
- PCOS — managed with lifestyle changes, letrozole, or metformin
- Endometriosis — treated with laparoscopic surgery prior to IVF
- Fibroids or polyps — surgically removed if affecting the uterine cavity
- Thyroid disorders — corrected with medication, often restoring natural fertility
Lifestyle Factors That Support Fertility Over 35
Research consistently shows that the following lifestyle changes improve fertility outcomes and IVF success rates:
- Maintaining a healthy body weight (BMI 18.5–24.9)
- Following an anti-inflammatory, Mediterranean-style diet
- Avoiding smoking — smoking accelerates ovarian aging and significantly reduces IVF success
- Limiting alcohol and caffeine
- Managing stress through regular exercise, sleep, and mindfulness
When to Seek Help
If you are over 35, do not wait the full 12 months before seeking an evaluation. The ASRM recommends evaluation after just 6 months of trying and sooner if you have known risk factors such as irregular periods, endometriosis, PCOS, or a history of pelvic infections.
Time matters. Earlier evaluation means earlier treatment and better outcomes.
Schedule Your Women’s Health Appointment with IVANA MD
If you are over 35 and have questions about your fertility, our experienced women’s health team in Missouri City, TX is here to help. We provide comprehensive fertility evaluations, personalized treatment planning, and the compassionate care every woman deserves.
Call: 346-585-4077
4220 Cartwright Road, Suite 201, Missouri City, Texas 77459
This blog is for educational purposes only and does not constitute medical advice. Always consult a qualified women’s health provider for evaluation and treatment of infertility.
References
- Leridon H. (2004). Can assisted reproduction technology compensate for the natural decline in fertility with age? Human Reproduction, 19(7), 1548–1553.
- Legro RS, et al. (2014). Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 371, 119–129.
- CDC. (2021). Assisted Reproductive Technology National Summary Report. www.cdc.gov/art
- Ubaldi FM, et al. (2015). Preimplantation genetic diagnosis in patients with recurrent implantation failure. Fertility and Sterility, 104(2), 323–330.
- Chavarro JE, et al. (2018). Diet and lifestyle in the prevention of ovulatory disorder infertility. Fertility and Sterility, 110(4), 629–630.
